High Court Urged By Doctors To Uphold Myriad Gene Patents
A group of doctors told the U.S. Supreme Court on Thursday that Myriad Genetics Inc. should be allowed to patent breast cancer genes it isolated, saying such protection fosters innovation in...To view the full article, register now.
Already a subscriber? Click here to view full article